Literature DB >> 15300361

Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies.

David M Raffel1, Wei Chen.   

Abstract

The norepinephrine transporter (NET) is the carrier that drives the neuronal norepinephrine uptake mechanism (uptake1) in mammalian hearts. The radioligand [3H]mazindol binds with high affinity to NET. In this study, the kinetics of [3H]mazindol binding to NET were measured using a rat heart membrane preparation. Results from these studies were used to set up saturation binding assays designed to measure cardiac NET densities (Bmax) and competitive inhibition assays designed to measure inhibitor binding affinities (KI) for NET. Saturation binding assays measured NET densities in rat, rabbit, and canine hearts. Assay reproducibility was assessed and the effect of NaCl concentration on [3H]mazindol binding to NET was studied using membranes from rat and canine hearts. Specificity of [3H]mazindol binding to NET was determined in experiments in which the neurotoxin 6-hydroxydopamine (6-OHDA) was used to selectively destroy cardiac sympathetic nerve terminals in rats. Competitive inhibition studies measured KI values for several NET inhibitors and substrates. In kinetic studies using rat heart membranes, [3H]mazindol exhibited a dissociation rate constant koff=0.0123+/-0.0007 min(-1) and an association rate constant kon=0.0249+/-0.0019 nM(-1)min(-1). In saturation binding assays, [3H]mazindol binding was monophasic and saturable in all cases. Increasing the concentration of NaCl in the assay buffer increased binding affinity significantly, while only modestly increasing Bmax. Injections of 6-OHDA in rats decreased measured cardiac NET Bmax values in a dose-dependent manner, verifying that [3H]mazindol binds specifically to NET from sympathetic nerve terminals. Competitive inhibition studies provided NET inhibitor and substrate KI values consistent with previously reported values. These studies demonstrate the high selectivity of [3H]mazindol binding for the norepinephrine transporter in membrane preparations from mammalian hearts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300361     DOI: 10.1007/s00210-004-0949-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure.

Authors:  H Kawai; A Mohan; J Hagen; E Dong; J Armstrong; S Y Stevens; C S Liang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

2.  Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.

Authors:  J Michael-Hepp; B Blum; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

Review 3.  Diabetic autonomic neuropathy and the heart.

Authors:  D J Ewing
Journal:  Diabetes Res Clin Pract       Date:  1996-02       Impact factor: 5.602

4.  Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier.

Authors:  E Schömig; M Körber; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

5.  High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline.

Authors:  R Raisman; M Sette; C Pimoule; M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1982-03-12       Impact factor: 4.432

Review 6.  Myocardial ischaemia and the cardiac nervous system.

Authors:  J A Armour
Journal:  Cardiovasc Res       Date:  1999-01       Impact factor: 10.787

7.  Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging.

Authors:  Yasushi Kiyono; Naoki Kanegawa; Hidekazu Kawashima; Yasuhiko Iida; Tomoko Kinoshita; Nagara Tamaki; Hiroshi Nishimura; Mikako Ogawa; Hideo Saji
Journal:  Nucl Med Biol       Date:  2002-08       Impact factor: 2.408

8.  Myocardial imaging with a radioiodinated norepinephrine storage analog.

Authors:  D M Wieland; L E Brown; W L Rogers; K C Worthington; J L Wu; N H Clinthorne; C A Otto; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

9.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

10.  Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies.

Authors:  Karine Mardon; Olivier Montagne; Nathalie Elbaz; Zoulikha Malek; André Syrota; Jean-Luc Dubois-Randé; Michel Meignan; Pascal Merlet
Journal:  J Nucl Med       Date:  2003-09       Impact factor: 10.057

View more
  7 in total

Review 1.  Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging.

Authors:  Nabil E Boutagy; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

2.  Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density.

Authors:  David M Raffel; Wei Chen; Phillip S Sherman; David L Gildersleeve; Yong-Woon Jung
Journal:  J Nucl Med       Date:  2006-09       Impact factor: 10.057

3.  Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts.

Authors:  Christoph Rischpler; Kenji Fukushima; Takuro Isoda; Mehrbod S Javadi; Robert F Dannals; Roselle Abraham; Richard Wahl; Frank M Bengel; Takahiro Higuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-29       Impact factor: 9.236

Review 4.  Assessment of cardiac autonomic neuronal function using PET imaging.

Authors:  James T Thackeray; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

5.  Radiotracers for cardiac sympathetic innervation: transport kinetics and binding affinities for the human norepinephrine transporter.

Authors:  David M Raffel; Wei Chen; Yong-Woon Jung; Keun Sam Jang; Guie Gu; Nicholas V Cozzi
Journal:  Nucl Med Biol       Date:  2013-01-08       Impact factor: 2.408

6.  Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

Authors:  James T Thackeray; Rob S Beanlands; Jean N Dasilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-20

7.  Altered levels of dopamine transporter in the frontal pole and dorsal striatum in schizophrenia.

Authors:  Hirotaka Sekiguchi; Geoff Pavey; Brian Dean
Journal:  NPJ Schizophr       Date:  2019-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.